Research Paper

Recent Advances in Physiological Functions and Biosynthesis of D-Allulose

Allulose has become a standard option for low sugar formulation You know its sweetness and bulk. But the ingredient’s value does not stop at the label. A 2022 review in Frontiers i

Allulose has become a standard option for low-sugar formulation

You know its sweetness and bulk. But the ingredient’s value does not stop at the label. A 2022 review in Frontiers in Microbiology (DOI: 10.3389/fmicb.2022.881037) collects the latest evidence on D-allulose’s physiological effects and the ways manufacturers can make it.

Why this background matters

Buyers and formulators often focus on sweetness and bulk. Those properties matter. Yet the same molecule that replaces sucrose also shows biological activity. The review lists anti-obesity, blood glucose-lowering, anti-diabetic, anti-inflammatory, antioxidant and neuroprotective effects. That is a wide range. For food developers, it shifts the conversation from “what does allulose replace?” to “what does allulose do?”

One number stands out. In normal adults, adding 5 grams of D-allulose significantly suppressed the blood glucose spike after 75 grams of maltodextrin. That is a small dose. That is also a meaningful response in a simple carbohydrate context.

What the study did

This is a review, not a single clinical trial. The authors compiled recent findings on D-allulose’s physiology and biosynthesis. They organized the production side around two strategies: the Izumoring strategy and a DHAP-dependent aldolase strategy. Both deal with making D-allulose. The review connects biological evidence and production options in one place.

Key findings at a glance

Health area Reported effect
Obesity Anti-obesity action
Blood glucose 5 g D-allulose inhibited glucose rise from 75 g maltodextrin
Diabetes Hypoglycemic and anti-diabetic effects
Inflammation Anti-inflammatory activity
Oxidative stress Antioxidant effects
Nervous system Neuroprotective action

That table summarizes the physiological side. The biosynthetic side matters for suppliers. The Izumoring strategy is one route. The DHAP-dependent aldolase strategy is another.

What this means for manufacturers

You can talk about allulose in two ways. First, as a sweetener and bulking agent. Second, as a functional carbohydrate with documented biological effects. That second story matters for new product development. It also matters for ingredient sourcing.

For buyers, the dose data gives a useful reference point. Five grams of D-allulose produced a measurable effect in the maltodextrin challenge. That benchmark gives you a concrete number to discuss with your R&D team. You do not need to invent a health claim. You do need to know what your suppliers can provide consistently.

The biosynthesis angle matters for production planning. The review looks at the Izumoring strategy and a DHAP-dependent aldolase strategy. That tells you the manufacturing science is not static. When you talk to suppliers, ask which route they run. Ask how it affects their output. The paper does not give a direct commercial comparison, but the science behind each route will shape availability down the line.

FAQ

Does 5 grams of D-allulose blunt blood glucose in real products? The review reports that effect in normal adults after a 75-gram maltodextrin load. That is a clean experimental condition. Real foods are more complex, but the number is still a useful benchmark.

What are the main physiological benefits? The review covers anti-obesity, blood glucose control, anti-diabetic, anti-inflammatory, antioxidant and neuroprotective effects. These come from a range of studies. The quality of evidence varies, so treat them as emerging.

Which production strategy should I follow? The review covers the Izumoring strategy and the DHAP-dependent aldolase strategy. The right choice depends on your supplier’s process and product needs. Watch both routes.

Allulose has moved beyond the sweetener aisle. It is a functional carbohydrate with biological data behind it. The 5-gram dose point gives you a starting place for formulation decisions. The biosynthesis review shows that production options are advancing. Use both pieces of information in your next supplier conversation. They will make you a sharper buyer.

Research Source

DOI: 10.3389/fmicb.2022.881037

View original paper

Need Allulose Application Guidance?

Our technical team can help evaluate allulose for sugar reduction, texture, browning, and label-planning projects.